Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation

Human Molecular Genetics

Volumn 20, Issue 24, 2011, Pages 4947-4977

  Ambegaokar, Surendra S ^a   Jackson, George R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CELL PROTEIN; CHROMATIN BINDING PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; EPITOPE; GLYCOGEN SYNTHASE KINASE 3BETA; HSP70 HSP90 ORGANIZING PROTEIN; KINESIN; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; POLYGLUTAMINE; PROTEIN; PROTEINASE ACTIVATED RECEPTOR 1; RNA BINDING PROTEIN; SONIC HEDGEHOG PROTEIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLELE; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL CYCLE; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; FUNCTIONAL GENOMICS; GENE DOSAGE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC SCREENING; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TAUOPATHY; UPREGULATION; WILD TYPE;

AMYLOID BETA-PEPTIDES; ANIMALS; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; EYE; GENE REGULATORY NETWORKS; GENES, MODIFIER; GENES, SUPPRESSOR; GENETIC TESTING; GENOMICS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MAP KINASE KINASE KINASE 1; MUTANT PROTEINS; NEUROTOXINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES;

EID: 81855172495     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr432     Document Type: Article

References (360)

1. Iqbal, K., Alonso, A.D.C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A. et al. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta, 1739, 198-210.
2. Galpern, W.R. and Lang, A.E. (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann. Neurol., 59, 449-458.
3. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702-705.
4. Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M. and Schellenberg, G.D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol., 43, 815-825.
5. Binder, L.I., Frankfurter, A. and Rebhun, L.I. (1985) The distribution of tau in the mammalian central nervous system. J. Cell Biol., 101, 1371-1378.
6. LoPresti, P., Szuchet, S., Papasozomenos, S.C., Zinkowski, R.P. and Binder, L.I. (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA, 92, 10369-10373.
7. Goedert, M., Spillantini, M.G., Potier, M.C., Ulrich, J. and Crowther, R.A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J., 8, 393-399.
8. Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W.W., Huang, E.J., Shen, Y., Masliah, E., Mukherjee, C. et al. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron, 67, 953-966.
9. Cohen, T.J., Guo, J.L., Hurtado, D.E., Kwong, L.K., Mills, I.P., Trojanowski, J.Q. and Lee, V.M.Y. (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun., 2, 252.
10. Arnold, C.S., Johnson, G.V., Cole, R.N., Dong, D.L., Lee, M. and Hart, G.W. (1996) The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J. Biol. Chem., 271, 28741-28744.
11. Reynolds, M.R., Berry, R.W. and Binder, L.I. (2005) Site-specific nitration differentially influences tau assembly in vitro. Biochemistry, 44, 13997-14009.
12. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G.W. and Gong, C.-X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl Acad. Sci. USA, 101, 10804-10809.
13. Gong, C.-X., Liu, F., Grundke-Iqbal, I. and Iqbal, K. (2005) Post-translational modifications of tau protein in Alzheimer's disease. J. Neural Transm., 112, 813-838.
14. Bednarski, E. and Lynch, G. (1996) Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem., 67, 1846-1855.
15. Hamano, T., Gendron, T.F., Causevic, E., Yen, S.-H., Lin, W.-L., Isidoro, C., Deture, M. and Ko, L.-W. (2008) Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur. J. Neurosci., 27, 1119-1130.
16. Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G. et al. (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet., 13, 703-714.
17. Shimura, H., Schwartz, D., Gygi, S.P. and Kosik, K.S. (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem., 279, 4869-4876.
18. Sengupta, S., Horowitz, P.M., Karsten, S.L., Jackson, G.R., Geschwind, D.H., Fu, Y., Berry, R.W. and Binder, L.I. (2006) Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. Biochemistry, 45, 15111-15119.
19. Kudo, L.C., Parfenova, L., Ren, G., Vi, N., Hui, M., Ma, Z., Lau, K., Gray, M., Bardag-Gorce, F., Wiedau-Pazos, M. et al. (2011) Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAUP301L double transgenic mice. Hum. Mol. Genet. doi:10.1093/hmg/ddr065.
20. Kosik, K.S., Joachim, C.L. and Selkoe, D.J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl Acad. Sci. USA, 83, 4044-4048.
21. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. and Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA, 83, 4913-4917.
22. Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95-130.
23. Hanger, D.P., Anderton, B.H. and Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med., 15, 112-119.
24. Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.P. and Anderton, B.H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett., 147, 58-62.
25. Mandelkow, E.M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J.R. and Mandelkow, E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett., 314, 315-321.
26. Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.M. and Mandelkow, E. (1997) MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell, 89, 297-308.
27. Baumann, K., Mandelkow, E.M., Biernat, J., Piwnica-Worms, H. and Mandelkow, E. (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases Cdk2 and Cdk5. FEBS Lett., 336, 417-424.
28. Kobayashi, S., Ishiguro, K., Omori, A., Takamatsu, M., Arioka, M., Imahori, K. and Uchida, T. (1993) A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett., 335, 171-175.
29. Drewes, G., Lichtenberg-Kraag, B., Döring, F., Mandelkow, E.M., Biernat, J., Goris, J., Dorée, M. and Mandelkow, E. (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J., 11, 2131-2138.
30. Goedert, M., Cohen, E.S., Jakes, R. and Cohen, P. (1992) p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1: implications for Alzheimer's disease [corrected]. FEBS Lett., 312, 95-99.
31. Litersky, J.M. and Johnson, G.V. (1992) Phosphorylation by CAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem., 267, 1563-1568.
32. Jicha, G.A., O'Donnell, A., Weaver, C., Angeletti, R. and Davies, P. (1999) Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase. J. Neurochem., 72, 214-224.
33. Reynolds, C.H., Nebreda, A.R., Gibb, G.M., Utton, M.A. and Anderton, B.H. (1997) Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem., 69, 191-198.
34. Reynolds, C.H., Utton, M.A., Gibb, G.M., Yates, A. and Anderton, B.H. (1997) Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J. Neurochem., 68, 1736-1744.
35. Drechsel, D.N., Hyman, A.A., Cobb, M.H. and Kirschner, M.W. (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell, 3, 1141-1154.
36. Gustke, N., Steiner, B., Mandelkow, E.M., Biernat, J., Meyer, H.E., Goedert, M. and Mandelkow, E. (1992) The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett., 307, 199-205.
37. Raffaelli, N., Yamauchi, P.S. and Purich, D.L. (1992) Microtubule-associated protein autophosphorylation alters in vitro microtubule dynamic instability. FEBS Lett., 296, 21-24.
38. Wada, Y., Ishiguro, K., Itoh, T.J., Uchida, T., Hotani, H., Saito, T., Kishimoto, T. and Hisanaga, S. (1998) Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by Cdk5 decreases its microtubule nucleation activity. J. Biochem., 124, 738-746.
39. Feijoo, C., Campbell, D.G., Jakes, R., Goedert, M. and Cuenda, A. (2005) Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly. J. Cell Sci., 118, 397-408.
40. Thies, E. and Mandelkow, E.-M. (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci., 27, 2896-2907.
41. Steinhilb, M.L., Dias-Santagata, D., Fulga, T.A., Felch, D.L. and Feany, M.B. (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol. Biol. Cell, 18, 5060-5068.
42. Chatterjee, S., Sang, T.-K., Lawless, G.M. and Jackson, G.R. (2009) Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet., 18, 164-177.
43. Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M.K., Trojanowski, J.Q. and Lee, V.M. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron, 24, 751-762.
44. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Paul Murphy, M., Baker, M., Yu, X. et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet., 25, 402-405.
45. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science, 293, 711-714.
46. Kraemer, B.C., Zhang, B., Leverenz, J.B., Thomas, J.H., Trojanowski, J.Q. and Schellenberg, G.D. (2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl Acad. Sci. USA, 100, 9980-9985.
47. Jackson, G.R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron, 34, 509-519.
48. Karsten, S.L., Sang, T.-K., Gehman, L.T., Chatterjee, S., Liu, J., Lawless, G.M., Sengupta, S., Berry, R.W., Pomakian, J., Oh, H.S. et al. (2006) A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron, 51, 549-560.
49. Spradling, A.C., Stern, D., Beaton, A., Rhem, E.J., Laverty, T., Mozden, N., Misra, S. and Rubin, G.M. (1999) The Berkeley Drosophila Genome Project gene disruption project: single P-element insertions mutating 25% of vital Drosophila genes. Genetics, 153, 135-177.
50. Bellen, H.J., Levis, R.W., Liao, G., He, Y., Carlson, J.W., Tsang, G., Evans-Holm, M., Hiesinger, P.R., Schulze, K.L., Rubin, G.M. et al. (2004) The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes. Genetics, 167, 761-781.
51. Rørth, P. (1996) A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl Acad. Sci. USA, 93, 12418-12422.
52. Shulman, J.M. and Feany, M.B. (2003) Genetic modifiers of tauopathy in Drosophila. Genetics, 165, 1233-1242.
53. Grether, M.E., Abrams, J.M., Agapite, J., White, K. and Steller, H. (1995) The head involution defective gene of Drosophila melanogaster functions in programmed cell death. Gen. Dev., 9, 1694-1708.
54. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet., 9, 13-25.
55. Lin, M.T. and Beal, M.F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443, 787-795.
56. Su, B., Wang, X., Zheng, L., Perry, G., Smith, M.A. and Zhu, X. (2010) Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim. Biophys. Acta, 1802, 135-142.
57. Moreira, P.I., Carvalho, C., Zhu, X., Smith, M.A. and Perry, G. (2010) Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim. Biophys. Acta, 1802, 2-10.
58. Damiano, M., Galvan, L., Déglon, N. and Brouillet, E. (2010) Mitochondria in Huntington's disease. Biochim. Biophys. Acta, 1802, 52-61.
59. Quintanilla, R.A. and Johnson, G.V.W. (2009) Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res. Bull., 80, 242-247.
60. Willy, P.J. (2000) A basal transcription factor that activates or represses transcription. Science, 290, 982-984.
61. Ambegaokar, S.S. and Jackson, G.R. (2010) Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster. Genetics, 186, 435-442.
62. Aerts, S., Vilain, S., Hu, S., Tranchevent, L.-C., Barriot, R., Yan, J., Moreau, Y., Hassan, B.A. and Quan, X.-J. (2009) Integrating computational biology and forward genetics in Drosophila. PLoS Genet., 5, e1000351.
63. Grossman, I., Lutz, M.W., Crenshaw, D.G., Saunders, A.M., Burns, D.K. and Roses, A.D. (2010) Alzheimer's disease: diagnostics, prognostics and the road to prevention. EPMA J., 1, 293-303.
64. Yoshii, S.R., Kishi, C., Ishihara, N. and Mizushima, N. (2011) Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem, 286, 19630-19640.
65. Li, Q., Vande Velde, C., Israelson, A., Xie, J., Bailey, A.O., Dong, M.-Q., Chun, S.-J., Roy, T., Winer, L., Yates, J.R. et al. (2010) ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl Acad. Sci. USA, 107, 21146-21151.
66. Yang, C.-S. and Weiner, H. (2002) Yeast two-hybrid screening identifies binding partners of human Tom34 that have ATPase activity and form a complex with Tom34 in the cytosol. Arch. Biochem. Biophys., 400, 105-110.
67. Tsaytler, P.A., Krijgsveld, J., Goerdayal, S.S., Rüdiger, S. and Egmond, M.R. (2009) Novel Hsp90 partners discovered using complementary proteomic approaches. Cell Stress Chaperones, 14, 629-638.
68. Fan, A.C.Y. and Young, J.C. (2011) Function of cytosolic chaperones in Tom70-mediated mitochondrial import. Protein Pept. Lett., 18, 122-131.
69. Yamamoto, H., Fukui, K., Takahashi, H., Kitamura, S., Shiota, T., Terao, K., Uchida, M., Esaki, M., Nishikawa, S.-I., Yoshihisa, T. et al. (2009) Roles of Tom70 in import of presequence-containing mitochondrial proteins. J. Biol. Chem., 284, 31635-31646.
70. Pollack, B.P., Kotenko, S.V., He, W., Izotova, L.S., Barnoski, B.L. and Pestka, S. (1999) The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J. Biol. Chem., 274, 31531-31542.
71. Anne, J., Ollo, R., Ephrussi, A. and Mechler, B.M. (2007) Arginine methyltransferase Capsuleen is essential for methylation of spliceosomal Sm proteins and germ cell formation in Drosophila. Development, 134, 137-146.
72. Nishida, K.M., Okada, T.N., Kawamura, T., Mituyama, T., Kawamura, Y., Inagaki, S., Huang, H., Chen, D., Kodama, T., Siomi, H. et al. (2009) Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines. EMBO J., 28, 3820-3831.
73. Gadir, N., Haim-Vilmovsky, L., Kraut-Cohen, J. and Gerst, J.E. (2011) Localization of mRNAs coding for mitochondrial proteins in the yeast Saccharomyces cerevisiae. RNA, 17, 1551-1565.
74. Li, L.-B., Yu, Z., Teng, X. and Bonini, N.M. (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature, 453, 1107-1111.
75. Daughters, R.S., Tuttle, D.L., Gao, W., Ikeda, Y., Moseley, M.L., Ebner, T.J., Swanson, M.S. and Ranum, L.P.W. (2009) RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet., 5, e1000600.
76. Yue, S., Serra, H.G., Zoghbi, H.Y. and Orr, H.T. (2001) The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum. Mol. Genet., 10, 25-30.
77. Fernandez-Funez, P., Nino-Rosales, M.L., de Gouyon, B., She, W.C., Luchak, J.M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P.J. et al. (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature, 408, 101-106.
78. Mutsuddi, M., Marshall, C.M., Benzow, K.A., Koob, M.D. and Rebay, I. (2004) The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr. Biol., 14, 302-308.
79. Murata, T., Suzuki, E., Ito, S., Sawatsubashi, S., Zhao, Y., Yamagata, K., Tanabe, M., Fujiyama, S., Kimura, S., Ueda, T. et al. (2008) RNA-binding protein hoip accelerates polyQ-induced neurodegeneration in Drosophila. Biosci. Biotechnol. Biochem., 72, 2255-2261.
80. Biernat, J., Mandelkow, E.M., Schroter, C., Lichtenberg-Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A., Goedert, M. et al. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J., 11, 1593-1597.
81. Wray, S., Saxton, M., Anderton, B.H. and Hanger, D.P. (2008) Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. J. Neurochem., 105, 2343-2352.
82. Ferrer, I., Barrachina, M., Tolnay, M., Rey, M.J., Vidal, N., Carmona, M., Blanco, R. and Puig, B. (2003) Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Brain Pathol., 13, 62-78.
83. Ikura, Y., Kudo, T., Tanaka, T., Tanii, H., Grundke-Iqbal, I., Iqbal, K. and Takeda, M. (1998) Levels of tau phosphorylation at different sites in Alzheimer disease brain. Neuroreport, 9, 2375-2379.
84. Han, D., Qureshi, H.Y., Lu, Y. and Paudel, H.K. (2009) Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro. J. Biol. Chem., 284, 13422-13433.
85. Seubert, P., Mawal-Dewan, M., Barbour, R., Jakes, R., Goedert, M., Johnson, G.V., Litersky, J.M., Schenk, D., Lieberburg, I. and Trojanowski, J.Q. (1995) Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem., 270, 18917-18922.
86. Goedert, M., Jakes, R., Crowther, R.A., Cohen, P., Vanmechelen, E., Vandermeeren, M. and Cras, P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J., 301, 871-877.
87. Inoue, H., Tateno, M., Fujimura-Kamada, K., Takaesu, G., Adachi-Yamada, T., Ninomiya-Tsuji, J., Irie, K., Nishida, Y. and Matsumoto, K. (2001) A Drosophila MAPKKK, D-MEKK1, mediates stress responses through activation of p38 MAPK. EMBO J., 20, 5421-5430.
88. Junttila, M.R., Li, S.-P. and Westermarck, J. (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J., 22, 954-965.
89. Casas-Tinto, S., Zhang, Y., Sanchez-Garcia, J., Gomez-Velazquez, M., Rincon-Limas, D.E. and Fernandez-Funez, P. (2011) The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. Hum. Mol. Genet., 20, 2144-2160.
90. Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., Meyer, H.E., Mandelkow, E.M. and Mandelkow, E. (1995) Microtubule-associated protein/microtubule affinity-regulating kinase (p110MARK): a novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J. Biol. Chem., 270, 7679-7688.
91. Hernández, F., Borrell, J., Guaza, C., Avila, J. and Lucas, J.J. (2002) Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J. Neurochem., 83, 1529-1533.
92. Nishimura, I., Yang, Y. and Lu, B. (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell, 116, 671-682.
93. Hooper, C., Killick, R. and Lovestone, S. (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem., 104, 1433-1439.
94. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D. et al. (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry, 9, 522-530.
95. Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B. et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl Acad. Sci. USA, 102, 6990-6995.
96. Miyasaka, T., Ding, Z., Gengyo-Ando, K., Oue, M., Yamaguchi, H., Mitani, S. and Ihara, Y. (2005) Progressive neurodegeneration in C. elegans model of tauopathy. Neurobiol. Dis., 20, 372-383.
97. Kraemer, B.C., Burgess, J.K., Chen, J.H., Thomas, J.H. and Schellenberg, G.D. (2006) Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum. Mol. Genet., 15, 1483-1496.
98. Blard, O., Feuillette, S., Bou, J., Chaumette, B., Frébourg, T., Campion, D. and Lecourtois, M. (2007) Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Hum. Mol. Genet., 16, 555-566.
99. Folwell, J., Cowan, C.M., Ubhi, K.K., Shiabh, H., Newman, T.A., Shepherd, D. and Mudher, A. (2009) Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Exp. Neurol., 223, 401-409.
100. Sofola, O., Kerr, F., Rogers, I., Killick, R., Augustin, H., Gandy, C., Allen, M.J., Hardy, J., Lovestone, S. and Partridge, L. (2010) Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet., 6, e1001087.
101. Lei, P., Ayton, S., Bush, A.I. and Adlard, P.A. (2011) GSK-3 in neurodegenerative diseases. Int. J. Alz. Dis. doi: 10.4061/2011/189246.
102. Hasegawa, M., Arai, T., Nonaka, T., Kametani, F., Yoshida, M., Hashizume, Y., Beach, T.G., Buratti, E., Baralle, F., Morita, M. et al. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol., 64, 60-70.
103. Geser, F., Lee, V.M.-Y. and Trojanowski, J.Q. (2010) Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology, 30, 103-112.
104. Cadigan, K.M. and Liu, Y.I. (2006) Wnt signaling: complexity at the surface. J. Cell Sci., 119, 395-402.
105. Liang, J. and Slingerland, J.M. (2003) Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle, 2, 339-345.
106. Wang, Y., McMahon, A.P. and Allen, B.L. (2007) Shifting paradigms in Hedgehog signaling. Curr. Opin. Cell Biol., 19, 159-165.
107. Willert, K. and Nusse, R. (1998) Beta-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev., 8, 95-102.
108. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. and Hemmings, B.A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
109. Cohen, P., Alessi, D.R. and Cross, D.A. (1997) PDK1, one of the missing links in insulin signal transduction? FEBS Lett., 410, 3-10.
110. Craft, S. (2005) Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging, 26, 65-69.
111. Cole, G.M. and Frautschy, S.A. (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease. Exp. Gerontol., 42, 10-21.
112. Zhao, W.-Q. and Townsend, M. (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim. Biophys. Acta, 1792, 482-496.
113. Erol, A. (2009) Unraveling the molecular mechanisms behind the metabolic basis of sporadic Alzheimer's disease. J. Alz. Dis., 17, 267-276.
114. Manolopoulos, K.N., Klotz, L.-O., Korsten, P., Bornstein, S.R. and Barthel, A. (2010) Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol. Psychiatry, 15, 1046-1052.
115. Cavallo, R.A., Cox, R.T., Moline, M.M., Roose, J., Polevoy, G.A., Clevers, H., Peifer, M. and Bejsovec, A. (1998) Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature, 395, 604-608.
116. Jia, J., Amanai, K., Wang, G., Tang, J., Wang, B. and Jiang, J. (2002) Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus. Nature, 416, 548-552.
117. Price, M.A. and Kalderon, D. (2002) Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell, 108, 823-835.
118. Kalderon, D. (2002) Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol., 12, 523-531.
119. Kosuga, S., Tashiro, E., Kajioka, T., Ueki, M., Shimizu, Y. and Imoto, M. (2005) GSK-3beta directly phosphorylates and activates MARK2/PAR-1. J. Biol. Chem., 280, 42715-42722.
120. Timm, T., Li, X.-Y., Biernat, J., Jiao, J., Mandelkow, E., Vandekerckhove, J. and Mandelkow, E.-M. (2003) MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J., 22, 5090-5101.
121. Timm, T., Balusamy, K., Li, X., Biernat, J., Mandelkow, E. and Mandelkow, E.-M. (2008) Glycogen synthase kinase (GSK) 3b directly phosphorylates Serine 212 in the regulatory loop and inhibits microtubule affinity-regulating kinase (MARK) 2. J. Biol. Chem., 283, 18873-18882.
122. Lizcano, J.M., Göransson, O., Toth, R., Deak, M., Morrice, N.A., Boudeau, J., Hawley, S.A., Udd, L., Mäkelä, T.P., Hardie, D.G. et al. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J., 23, 833-843.
123. Wang, J.-W., Imai, Y. and Lu, B. (2007) Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J. Neurosci., 27, 574-581.
124. Green, J.B.A. (2004) Lkb1 and GSK3-beta: kinases at the center and poles of the action. Cell Cycle, 3, 12-14.
125. Dickey, C.A., Koren, J., Zhang, Y.-J., Xu, Y.-F., Jinwal, U.K., Birnbaum, M.J., Monks, B., Sun, M., Cheng, J.Q., Patterson, C. et al. (2008) Akt and CHIP coregulate tau degradation through coordinated interactions. Proc. Natl Acad. Sci. USA, 105, 3622-3627.
126. Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E. and Mandelkow, E.M. (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry, 38, 3549-3558.
127. Hoover, B.R., Reed, M.N., Su, J., Penrod, R.D., Kotilinek, L.A., Grant, M.K., Pitstick, R., Carlson, G.A., Lanier, L.M., Yuan, L.-L. et al. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron, 68, 1067-1081.
128. Pooler, A.M., Usardi, A., Evans, C.J., Philpott, K.L., Noble, W. and Hanger, D.P. (2011) Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol. Aging, 10.1016/j.neurobiolaging.2011.01.005.
129. Ittner, L.M., Ke, Y.D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B.C., Christie, M.J., Napier, I.A. et al. (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell, 142, 387-397.
130. Pei, J.-J., Braak, H., An, W.-L., Winblad, B., Cowburn, R.F., Iqbal, K. and Grundke-Iqbal, I. (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res. Mol. Brain Res., 109, 45-55.
131. Ferrer, I., Blanco, R., Carmona, M., Ribera, R., Goutan, E., Puig, B., Rey, M.J., Cardozo, A., Viñals, F. and Ribalta, T. (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol., 11, 144-158.
132. Amadoro, G., Ciotti, M.T., Costanzi, M., Cestari, V., Calissano, P. and Canu, N. (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc. Natl Acad. Sci. USA, 103, 2892-2897.
133. Therrien, M., Michaud, N.R., Rubin, G.M. and Morrison, D.K. (1996) KSR modulates signal propagation within the MAPK cascade. Gen. Dev., 10, 2684-2695.
134. Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D. and Therrien, M. (2002) KSR is a scaffold required for activation of the ERK/MAPK module. Gen. Dev., 16, 427-438.
135. García-Alonso, L., Romani, S. and Jiménez, F. (2000) The EGF and FGF receptors mediate neuroglian function to control growth cone decisions during sensory axon guidance in Drosophila. Neuron, 28, 741-752.
136. Islam, R., Kristiansen, L.V., Romani, S., Garcia-Alonso, L. and Hortsch, M. (2004) Activation of EGF receptor kinase by L1-mediated homophilic cell interactions. Mol. Biol. Cell, 15, 2003-2012.
137. Whittard, J.D., Sakurai, T., Cassella, M.R., Gazdoiu, M. and Felsenfeld, D.P. (2006) MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth. Mol. Biol. Cell, 17, 2696-2706.
138. Dubreuil, R.R., MacVicar, G., Dissanayake, S., Liu, C., Homer, D. and Hortsch, M. (1996) Neuroglian-mediated cell adhesion induces assembly of the membrane skeleton at cell contact sites. J. Cell Biol., 133, 647-655.
139. Bennett, V. and Lambert, S. (1999) Physiological roles of axonal ankyrins in survival of premyelinated axons and localization of voltage-gated sodium channels. J. Neurocytol., 28, 303-318.
140. Godenschwege, T.A., Kristiansen, L.V., Uthaman, S.B., Hortsch, M. and Murphey, R.K. (2006) A conserved role for Drosophila Neuroglian and human L1-CAM in central-synapse formation. Curr. Biol., 16, 12-23.
141. Shimada, T., Toriyama, M., Uemura, K., Kamiguchi, H., Sugiura, T., Watanabe, N. and Inagaki, N. (2008) Shootin1 interacts with actin retrograde flow and L1-CAM to promote axon outgrowth. J. Cell Biol., 181, 817-829.
142. Brun, S., Vidal, S., Spellman, P., Takahashi, K., Tricoire, H. and Lemaitre, B. (2006) The MAPKKK Mekk1 regulates the expression of Turandot stress genes in response to septic injury in Drosophila. Genes Cells, 11, 397-407.
143. Sano, Y., Akimaru, H., Okamura, T., Nagao, T., Okada, M. and Ishii, S. (2005) Drosophila activating transcription factor-2 is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase. Mol. Biol. Cell., 16, 2934-2946.
144. Zhuang, Z.-H., Zhou, Y., Yu, M.-C., Silverman, N. and Ge, B.-X. (2006) Regulation of Drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli. Cell Signal., 18, 441-448.
145. Hensley, K., Floyd, R.A., Zheng, N.Y., Nael, R., Robinson, K.A., Nguyen, X., Pye, Q.N., Stewart, C.A., Geddes, J., Markesbery, W.R. et al. (1999) p38 kinase is activated in the Alzheimer's disease brain. J. Neurochem., 72, 2053-2058.
146. Ferrer, I., Pastor, P., Rey, M.J., Muñoz, E., Puig, B., Pastor, E., Oliva, R. and Tolosa, E. (2003) Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol. Appl. Neurobiol., 29, 23-34.
147. Hartzler, A.W., Zhu, X., Siedlak, S.L., Castellani, R.J., Avilá, J., Perry, G. and Smith, M.A. (2002) The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau. Neurobiol. Aging, 23, 855-859.
148. Sahara, N., Vega, I.E., Ishizawa, T., Lewis, J., McGowan, E., Hutton, M., Dickson, D. and Yen, S.-H. (2004) Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins. J. Neurochem., 90, 829-838.
149. Kelleher, I., Garwood, C., Hanger, D.P., Anderton, B.H. and Noble, W. (2007) Kinase activities increase during the development of tauopathy in htau mice. J. Neurochem., 103, 2256-2267.
150. Oddo, S., Caccamo, A., Green, K.N., Liang, K., Tran, L., Chen, Y., Leslie, F.M. and Laferla, F.M. (2005) Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 102, 3046-3051.
151. Hwang, D.Y., Cho, J.S., Lee, S.H., Chae, K.R., Lim, H.J., Min, S.H., Seo, S.J., Song, Y.S., Song, C.W., Paik, S.G. et al. (2004) Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp. Neurol., 186, 20-32.
152. Zhu, X., Rottkamp, C.A., Boux, H., Takeda, A., Perry, G. and Smith, M.A. (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol., 59, 880-888.
153. Sun, A., Liu, M., Nguyen, X.V. and Bing, G. (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp. Neurol., 183, 394-405.
154. Puig, B., Vinals, F. and Ferrer, I. (2004) Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease. Acta Neuropathol., 107, 185-189.
155. Ferrer, I., Blanco, R., Carmona, M. and Puig, B. (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J. Neural Transm., 108, 1397-1415.
156. Bhaskar, K., Konerth, M., Kokiko-Cochran, O.N., Cardona, A., Ransohoff, R.M. and Lamb, B.T. (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron, 68, 19-31.
157. Yamanaka, H., Obata, K., Kobayashi, K., Dai, Y., Fukuoka, T. and Noguchi, K. (2007) Alteration of the cell adhesion molecule L1 expression in a specific subset of primary afferent neurons contributes to neuropathic pain. Eur. J. Neurosci., 25, 1097-1111.
158. La Pointe, N.E., Morfini, G., Pigino, G., Gaisina, I.N., Kozikowski, A.P., Binder, L.I. and Brady, S.T. (2009) The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J. Neurosci. Res., 87, 440-451.
159. Denko, N., Wernke-Dollries, K., Johnson, A.B., Hammond, E., Chiang, C.-M. and Barton, M.C. (2003) Hypoxia actively represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and blocking preinitiation complex assembly. J. Biol. Chem., 278, 5744-5749.
160. Akiyama, T. (2000) Wnt/beta-catenin signaling. Cytokine Growth Factor Rev., 11, 273-282.
161. Shevtsov, S.P., Haq, S. and Force, T. (2006) Activation of beta-catenin signaling pathways by classical G-protein-coupled receptors: mechanisms and consequences in cycling and non-cycling cells. Cell Cycle, 5, 2295-2300.
162. Kikuchi, A., Kishida, S. and Yamamoto, H. (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp. Mol. Med., 38, 1-10.
163. Butt, A.J., McNeil, C.M., Musgrove, E.A. and Sutherland, R.L. (2005) Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr. Relat. Cancer, 12, S47-S59.
164. Martinez-Vicente, M. and Cuervo, A.M. (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol., 6, 352-361.
165. Bahr, B.A. and Bendiske, J. (2002) The neuropathogenic contributions of lysosomal dysfunction. J. Neurochem., 83, 481-489.
166. Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A. and Cuervo, A.M. (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol., 64, 113-122.
167. Ma, J.-F., Huang, Y., Chen, S.-D. and Halliday, G. (2010) Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease. Neuropathol. Appl. Neurobiol., 36, 312-319.
168. Wong, E. and Cuervo, A.M. (2010) Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci., 13, 805-811.
169. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H. et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature, 441, 885-889.
170. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E. et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441, 880-884.
171. Pickford, F., Masliah, E., Britschgi, M., Lucin, K., Narasimhan, R., Jaeger, P.A., Small, S., Spencer, B., Rockenstein, E., Levine, B. et al. (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest., 118, 2190-2199.
172. Lim, F., Hernández, F., Lucas, J.J., Gómez-Ramos, P., Morán, M.A. and Avila, J. (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell Neurosci., 18, 702-714.
173. Murakami, N., Oyama, F., Gu, Y., McLennan, I.S., Nonaka, I. and Ihara, Y. (1998) Accumulation of tau in autophagic vacuoles in chloroquine myopathy. J. Neuropathol. Exp. Neurol., 57, 664-673.
174. Oyama, F., Murakami, N. and Ihara, Y. (1998) Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease. Neurosci. Res., 31, 1-8.
175. Bendiske, J. and Bahr, B.A. (2003) Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis-an approach for slowing Alzheimer disease? J. Neuropathol. Exp. Neurol., 62, 451-463.
176. Bi, X., Zhou, J. and Lynch, G. (1999) Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease. Exp. Neurol., 158, 312-327.
177. Blanchette-Mackie, E.J., Dwyer, N.K., Amende, L.M., Kruth, H.S., Butler, J.D., Sokol, J., Comly, M.E., Vanier, M.T., August, J.T. and Brady, R.O. (1988) Type-C Niemann-Pick disease: low-density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc. Natl Acad. Sci. USA, 85, 8022-8026.
178. Sokol, J., Blanchette-Mackie, J., Kruth, H.S., Dwyer, N.K., Amende, L.M., Butler, J.D., Robinson, E., Patel, S., Brady, R.O. and Comly, M.E. (1988) Type C Niemann-Pick disease: lysosomal accumulation and defective intracellular mobilization of low-density lipoprotein cholesterol. J. Biol. Chem., 263, 3411-3417.
179. Suzuki, K., Parker, C.C., Pentchev, P.G., Katz, D., Ghetti, B., D'Agostino, A.N. and Carstea, E.D. (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol., 89, 227-238.
180. Ohmi, K., Kudo, L.C., Ryazantsev, S., Zhao, H.-Z., Karsten, S.L. and Neufeld, E.F. (2009) Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc. Natl Acad. Sci. USA, 106, 8332-8337.
181. Dermaut, B., Norga, K.K., Kania, A., Verstreken, P., Pan, H., Zhou, Y., Callaerts, P. and Bellen, H.J. (2005) Aberrant lysosomal carbohydrate storage accompanies endocytic defects and neurodegeneration in Drosophila benchwarmer. J. Cell Biol., 170, 127-139.
182. Khurana, V., Elson-Schwab, I., Fulga, T.A., Sharp, K.A., Loewen, C.A., Mulkearns, E., Tyynelä, J., Scherzer, C.R. and Feany, M.B. (2010) Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet., 6, e1001026.
183. Dow, J.A. (1999) The multifunctional Drosophila melanogaster V-ATPase is encoded by a multigene family. J. Bioenerg. Biomembr., 31, 75-83.
184. Lee, J.-H., Yu, W.H., Kumar, A., Lee, S., Mohan, P.S., Peterhoff, C.M., Wolfe, D.M., Martinez-Vicente, M., Massey, A.C., Sovak, G. et al. (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell, 141, 1146-1158.
185. Williamson, W.R., Wang, D., Haberman, A.S. and Hiesinger, P.R. (2010) A dual function of V0-ATPase a1 provides an endolysosomal degradation mechanism in Drosophila melanogaster photoreceptors. J. Cell Biol., 189, 885-899.
186. Williamson, W.R. and Hiesinger, P.R. (2010) On the role of v-ATPase V0a1-dependent degradation in Alzheimer disease. Commun. Integr. Biol., 3, 604-607.
187. Shoup, J.R. (1966) The development of pigment granules in the eyes of wild type and mutant Drosophila melanogaster. J. Cell Biol., 29, 223-249.
188. Stark, W.S. and Sapp, R. (1988) Eye color pigment granules in wild-type and mutant Drosophila melanogaster. Can. J. Zool., 66, 1301-1308.
189. Ambegaokar, S.S. and Jackson, G.R. (2011) Double vision: pigment genes do more than just color. Fly, 5, 206-209.
190. Sarkar, S., Krishna, G., Imarisio, S., Saiki, S., O'Kane, C.J. and Rubinsztein, D.C. (2008) A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum. Mol. Genet., 17, 170-178.
191. Wang, S.-H., Shih, Y.-L., Kuo, T.-C., Ko, W.-C. and Shih, C.-M. (2009) Cadmium toxicity toward autophagy through ROS-activated GSK-3beta in mesangial cells. Toxic. Sci., 108, 124-131.
192. Zhou, X., Zhou, J., Li, X., Guo, C.A., Fang, T. and Chen, Z. (2011) GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury. Biochem. Biophys. Res. Commun., 411, 271-275.
193. Simonsen, A., Cumming, R.C., Lindmo, K., Galaviz, V., Cheng, S., Rusten, T.E. and Finley, K.D. (2007) Genetic modifiers of the Drosophila blue cheese gene link defects in lysosomal transport with decreased life span and altered ubiquitinated-protein profiles. Genetics, 176, 1283-1297.
194. Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C.J., Brown, S.D.M. and Rubinsztein, D.C. (2005) Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet., 37, 771-776.
195. Cai, Q., Lu, L., Tian, J.-H., Zhu, Y.-B., Qiao, H. and Sheng, Z.-H. (2010) Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron, 68, 73-86.
196. Klionsky, D.J. and Emr, S.D. (2000) Autophagy as a regulated pathway of cellular degradation. Science, 290, 1717-1721.
197. Boland, B., Kumar, A., Lee, S., Platt, F.M., Wegiel, J., Yu, W.H. and Nixon, R.A. (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci., 28, 6926-6937.
198. Dixit, R., Ross, J.L., Goldman, Y.E. and Holzbaur, E.L.F. (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science, 319, 1086-1089.
199. Kadota, Y., Niiya, A., Masaki, R., Yamamoto, A., Araki, M. and Taketani, S. (1997) A newly identified membrane protein localized exclusively in intracellular organelles of neurons. Brain Res. Mol. Brain Res., 46, 265-273.
200. Bilen, J. and Bonini, N.M. (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet., 3, 1950-1964.
201. Smith, D.F., Sullivan, W.P., Marion, T.N., Zaitsu, K., Madden, B., McCormick, D.J. and Toft, D.O. (1993) Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol. Cell. Biol., 13, 869-876.
202. Chang, H.C., Nathan, D.F. and Lindquist, S. (1997) In vivo analysis of the Hsp90 cochaperone Sti1 (p60). Mol. Cell Biol., 17, 318-325.
203. Johnson, B.D., Schumacher, R.J., Ross, E.D. and Toft, D.O. (1998) Hop modulates Hsp70/Hsp90 interactions in protein folding. J. Biol. Chem., 273, 3679-3686.
204. Dickey, C.A., Yue, M., Lin, W.-L., Dickson, D.W., Dunmore, J.H., Lee, W.C., Zehr, C., West, G., Cao, S., Clark, A.M.K. et al. (2006) Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci., 26, 6985-6996.
205. Grelle, G., Kostka, S., Otto, A., Kersten, B., Genser, K.F., Müller, E.-C., Wälter, S., Böddrich, A., Stelzl, U., Hänig, C. et al. (2006) Identification of VCP/p97, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II interaction partners using membrane-based human proteome arrays. Mol. Cell Proteomics, 5, 234-244.
206. Pandey, U.B., Nie, Z., Batlevi, Y., McCray, B.A., Ritson, G.P., Nedelsky, N.B., Schwartz, S.L., DiProspero, N.A., Knight, M.A., Schuldiner, O. et al. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 447, 859-863.
207. Casarejos, M.J., Solano, R.M., Gómez, A., Perucho, J., de Yébenes, J.G. and Mena, M.A. (2011) The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells. Neurochem. Int., 58, 512-520.
208. Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A.M. and Mandelkow, E. (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet., 18, 4153-4170.
209. Chow, K.M., Guan, H. and Hersh, L.B. (2010) Aminopeptidases do not directly degrade tau protein. Mol. Neurodegen., 5, 48.
210. Menzies, F.M., Hourez, R., Imarisio, S., Rarcel, R., Sadiq, O., Chandraratna, D., O'Kane, C.J., Rock, K.L., Reits, E., Goldberg, A.L. et al. (2010) Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Hum. Mol. Genet., 19, 4573-4586.
211. Park, S.-Y. and Ferreira, A. (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J. Neurosci., 25, 5365-5375.
212. Canu, N., Dus, L., Barbato, C., Ciotti, M.T., Brancolini, C., Rinaldi, A.M., Novak, M., Cattaneo, A., Bradbury, A. and Calissano, P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci., 18, 7061-7074.
213. Tanzi, R.E. and Bertram, L. (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell, 120, 545-555.
214. Esler, W.P. and Wolfe, M.S. (2001) A portrait of Alzheimer secretases-new features and familiar faces. Science, 293, 1449-1454.
215. Nelson, O., Supnet, C., Liu, H. and Bezprozvanny, I. (2010) Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. J. Alz. Dis., 21, 781-793.
216. Zhang, H., Sun, S., Herreman, A., De Strooper, B. and Bezprozvanny, I. (2010) Role of presenilins in neuronal calcium homeostasis. J. Neurosci., 30, 8566-8580.
217. De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J.S., Schroeter, E.H., Schrijvers, V., Wolfe, M.S., Ray, W.J. et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature, 398, 518-522.
218. Selva, E.M., Hong, K., Baeg, G.H., Beverley, S.M., Turco, S.J., Perrimon, N. and Häcker, U. (2001) Dual role of the fringe connection gene in both heparan sulphate and fringe-dependent signalling events. Nat. Cell Biol., 3, 809-815.
219. Goto, S., Taniguchi, M., Muraoka, M., Toyoda, H., Sado, Y., Kawakita, M. and Hayashi, S. (2001) UDP-sugar transporter implicated in glycosylation and processing of Notch. Nat. Cell Biol., 3, 816-822.
220. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B. and Mandelkow, E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol., 143, 777-794.
221. Trinczek, B., Ebneth, A., Mandelkow, E.M. and Mandelkow, E. (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci., 112, 2355-2367.
222. Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T. et al. (2000) Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem., 275, 41340-41349.
223. Vershinin, M., Xu, J., Razafsky, D.S., King, S.J. and Gross, S.P. (2008) Tuning microtubule-based transport through filamentous MAPs: the problem of dynein. Traffic, 9, 882-892.
224. Hagiwara, H., Yorifuji, H., Sato-Yoshitake, R. and Hirokawa, N. (1994) Competition between motor molecules (kinesin and cytoplasmic dynein) and fibrous microtubule-associated proteins in binding to microtubules. J. Biol. Chem., 269, 3581-3589.
225. Jancsik, V., Filliol, D. and Rendon, A. (1996) Tau proteins bind to kinesin and modulate its activation by microtubules. Neurobiology (Bp), 4, 417-429.
226. Cuchillo-Ibanez, I., Seereeram, A., Byers, H.L., Leung, K.-Y., Ward, M.A., Anderton, B.H. and Hanger, D.P. (2008) Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J., 22, 3186-3195.
227. Falzone, T.L., Stokin, G.B., Lillo, C., Rodrigues, E.M., Westerman, E.L., Williams, D.S. and Goldstein, L.S.B. (2009) Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J. Neurosci., 29, 5758-5767.
228. Falzone, T.L., Gunawardena, S., McCleary, D., Reis, G.F. and Goldstein, L.S. (2010) Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. Hum. Mol. Genet., 19, 4399-4408.
229. Bard, F., Casano, L., Mallabiabarrena, A., Wallace, E., Saito, K., Kitayama, H., Guizzunti, G., Hu, Y., Wendler, F., Dasgupta, R. et al. (2006) Functional genomics reveals genes involved in protein secretion and Golgi organization. Nature, 439, 604-607.
230. Itin, C., Ulitzur, N., Mühlbauer, B. and Pfeffer, S.R. (1999) Mapmodulin, cytoplasmic dynein, and microtubules enhance the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network. Mol. Biol. Cell, 10, 2191-2197.
231. Farah, C.A., Perreault, S., Liazoghli, D., Desjardins, M., Anton, A., Lauzon, M., Paiement, J. and Leclerc, N. (2006) Tau interacts with Golgi membranes and mediates their association with microtubules. Cell Motil. Cytoskel., 63, 710-724.
232. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.-M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol., 156, 1051-1063.
233. Yoshiyama, Y., Zhang, B., Bruce, J., Trojanowski, J.Q. and Lee, V.M.-Y. (2003) Reduction of detyrosinated microtubules and Golgi fragmentation are linked to tau-induced degeneration in astrocytes. J. Neurosci., 23, 10662-10671.
234. Hu, Z., Zeng, L., Huang, Z., Zhang, J. and Li, T. (2007) The study of Golgi apparatus in Alzheimer's disease. Neurochem. Res., 32, 1265-1277.
235. Fan, J., Hu, Z., Zeng, L., Lu, W., Tang, X., Zhang, J. and Li, T. (2008) Golgi apparatus and neurodegenerative diseases. Int. J. Dev. Neurosci., 26, 523-534.
236. Lin, W.-L., Lewis, J., Yen, S.-H., Hutton, M. and Dickson, D.W. (2003) Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. J. Neurocytol., 32, 1091-1105.
237. Liazoghli, D., Perreault, S., Micheva, K.D., Desjardins, M. and Leclerc, N. (2005) Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons. Am. J. Pathol., 166, 1499-1514.
238. Gonatas, N.K., Stieber, A. and Gonatas, J.O. (2006) Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci., 246, 21-30.
239. La Ferla, F.M. (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci., 3, 862-872.
240. Lindholm, D., Wootz, H. and Korhonen, L. (2006) ER stress and neurodegenerative diseases. Cell Death Differ., 13, 385-392.
241. Elyaman, W., Yardin, C. and Hugon, J. (2002) Involvement of glycogen synthase kinase-3β and tau phosphorylation in neuronal Golgi disassembly. J. Neurochem., 81, 870-880.
242. Cermelli, S., Guo, Y., Gross, S.P. and Welte, M.A. (2006) The lipid-droplet proteome reveals that droplets are a protein-storage depot. Curr. Biol., 16, 1783-1795.
243. Guo, Y., Walther, T.C., Rao, M., Stuurman, N., Goshima, G., Terayama, K., Wong, J.S., Vale, R.D., Walter, P. and Farese, R.V. (2008) Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature, 453, 657-661.
244. McManaman, J.L., Palmer, C.A., Wright, R.M. and Neville, M.C. (2002) Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion. J. Physiol., 545, 567-579.
245. Schmitz, G., Langmann, T. and Heimerl, S. (2001) Role of ABCG1 and other ABCG family members in lipid metabolism. J. Lipid Res., 42, 1513-1520.
246. Majdalawieh, A. and Ro, H.-S. (2010) PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nucl. Recept. Sig., 8, e004.
247. Matsuo, M., Campenot, R.B., Vance, D.E., Ueda, K. and Vance, J.E. (2011) Involvement of low-density lipoprotein receptor-related protein and ABCG1 in stimulation of axonal extension by apoE-containing lipoproteins. Biochim. Biophys. Acta, 1811, 31-38.
248. Reiss, A.B. (2005) Cholesterol and apolipoprotein E in Alzheimer's disease. Am. J. Alz. Dis. Dementias, 20, 91-96.
249. Lane, R.M. and Farlow, M.R. (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J. Lipid Res., 46, 949-968.
250. Bertram, L. (2011) Alzheimer's genetics in the GWAS era: a continuing story of 'replications and refutations'. Curr. Neurol. Neurosci. Rep., 11, 246-253.
251. Bullido, M.J., Aldudo, J., Frank, A., Coria, F., Avila, J. and Valdivieso, F. (2000) A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci. Lett., 278, 49-52.
252. Lilius, L., Froelich Fabre, S., Basun, H., Forsell, C., Axelman, K., Mattila, K., Andreadis, A., Viitanen, M., Winblad, B., Fratiglioni, L. et al. (1999) Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci. Lett., 277, 29-32.
253. Ingelson, M., Fabre, S.F., Lilius, L., Andersen, C., Viitanen, M., Almkvist, O., Wahlund, L.O. and Lannfelt, L. (2001) Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. Neuroreport, 12, 905-909.
254. Harris, F.M., Brecht, W.J., Xu, Q., Tesseur, I., Kekonius, L., Wyss-Coray, T., Fish, J.D., Masliah, E., Hopkins, P.C., Scearce-Levie, K. et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl Acad. Sci. USA, 100, 10966-10971.
255. Kobayashi, M., Ishiguro, K., Katoh-Fukui, Y., Yokoyama, M. and Fujita, S.C. (2003) Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice. Neuroreport, 14, 699-702.
256. Andrews-Zwilling, Y., Bien-Ly, N., Xu, Q., Li, G., Bernardo, A., Yoon, S.Y., Zwilling, D., Yan, T.X., Chen, L. and Huang, Y. (2010) Apolipoprotein e4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci., 30, 13707-13717.
257. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D. (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl Acad. Sci. USA, 91, 11183-11186.
258. Huang, D.Y., Weisgraber, K.H., Goedert, M., Saunders, A.M., Roses, A.D. and Strittmatter, W.J. (1995) ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neurosci. Lett., 192, 209-212.
259. Burns, M. and Duff, K. (2002) Cholesterol in Alzheimer's disease and tauopathy. Ann. NY Acad. Sci., 977, 367-375.
260. Mukherjee, S. and Maxfield, F.R. (2004) Lipid and cholesterol trafficking in NPC. Biochim. Biophys. Acta, 1685, 28-37.
261. Khaliullina, H., Panáková, D., Eugster, C., Riedel, F., Carvalho, M. and Eaton, S. (2009) Patched regulates Smoothened trafficking using lipoprotein-derived lipids. Development, 136, 4111-4121.
262. Koh, C.H.V., Qi, R.Z., Qu, D., Melendez, A., Manikandan, J., Bay, B.H., Duan, W. and Cheung, N.S. (2006) U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Sig., 18, 1572-1583.
263. Vereshchagina, N. and Wilson, C. (2006) Cytoplasmic activated protein kinase Akt regulates lipid-droplet accumulation in Drosophila nurse cells. Development, 133, 4731-4735.
264. Vereshchagina, N., Ramel, M.-C., Bitoun, E. and Wilson, C. (2008) The protein phosphatase PP2A-B' subunit Widerborst is a negative regulator of cytoplasmic activated Akt and lipid metabolism in Drosophila. J. Cell Sci., 121, 3383-3392.
265. Ghribi, O. (2008) Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. J. Alz. Dis., 15, 673-684.
266. Harris, J.R. and Milton, N.G.N. (2010) Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Subcell. Biochem., 51, 47-75.
267. Glöckner, F., Meske, V., Lütjohann, D. and Ohm, T.G. (2011) Dietary cholesterol and its effect on tau protein: a study in apolipoprotein E-deficient and P301L human tau mice. J. Neuropathol. Exp. Neurol., 70, 292-301.
268. Morley, J.E. and Banks, W.A. (2010) Lipids and cognition. J. Alz. Dis., 20, 737-747.
269. Distl, R., Meske, V. and Ohm, T.G. (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol., 101, 547-554.
270. Arendt, T. (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog. Neurobiol., 71, 83-248.
271. Webber, K.M., Raina, A.K., Marlatt, M.W., Zhu, X., Prat, M.I., Morelli, L., Casadesus, G., Perry, G. and Smith, M.A. (2005) The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mech. Ageing Dev., 126, 1019-1025.
272. Andorfer, C., Acker, C.M., Kress, Y., Hof, P.R., Duff, K. and Davies, P. (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci., 25, 5446-5454.
273. Khurana, V., Lu, Y., Steinhilb, M.L., Oldham, S., Shulman, J.M. and Feany, M.B. (2006) TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr. Biol., 16, 230-241.
274. Hoerndli, F.J., Pelech, S., Papassotiropoulos, A. and Götz, J. (2007) Abeta treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry. Eur. J. Neurosci., 26, 60-72.
275. Jaworski, T., Dewachter, I., Lechat, B., Croes, S., Termont, A., Demedts, D., Borghgraef, P., Devijver, H., Filipkowski, R.K., Kaczmarek, L. et al. (2009) AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice. PLoS ONE, 4, e7280.
276. Sauer, K., Knoblich, J.A., Richardson, H. and Lehner, C.F. (1995) Distinct modes of cyclin E/cdc2c kinase regulation and S-phase control in mitotic and endoreduplication cycles of Drosophila embryogenesis. Gen. Dev., 9, 1327-1339.
277. Lilly, M.A. and Spradling, A.C. (1996) The Drosophila endocycle is controlled by Cyclin E and lacks a checkpoint ensuring S-phase completion. Gen. Dev., 10, 2514-2526.
278. Schmetsdorf, S., Arnold, E., Holzer, M., Arendt, T. and Gärtner, U. (2009) A putative role for cell cycle-related proteins in microtubule-based neuroplasticity. Eur. J. Neurosci., 29, 1096-1107.
279. Paudel, H.K., Lew, J., Ali, Z. and Wang, J.H. (1993) Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem., 268, 23512-23518.
280. Preuss, U. and Mandelkow, E.M. (1998) Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease. Eur. J. Cell Biol., 76, 176-184.
281. Hua, Q. and He, R.-Q. (2002) Effect of phosphorylation and aggregation on tau binding to DNA. Protein Pept. Lett., 9, 349-357.
282. Goshima, G. and Vale, R.D. (2003) The roles of microtubule-based motor proteins in mitosis: comprehensive RNAi analysis in the Drosophila S2 cell line. J. Cell Biol., 162, 1003-1016.
283. Aleem, E., Kiyokawa, H. and Kaldis, P. (2005) Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat. Cell Biol., 7, 831-836.
284. Takai, N., Ueda, T., Nasu, K., Yamashita, S., Toyofuku, M. and Narahara, H. (2009) Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas. Cancer Lett., 277, 235-243.
285. Skelding, K.A., Rostas, J.A.P. and Verrills, N.M. (2011) Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II. Cell Cycle, 10, 631-639.
286. Condon, J.C., Pezzi, V., Drummond, B.M., Yin, S. and Rainey, W.E. (2002) Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology, 143, 3651-3657.
287. Xu, Q., Yu, L., Liu, L., Cheung, C.F., Li, X., Yee, S.-P., Yang, X.-J. and Wu, Z. (2002) p38 mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol. Biol. Cell, 13, 1940-1952.
288. Pedersen, M.E., Fortunati, D., Nielsen, M., Brorson, S.-H., Lekva, T., Nissen-Meyer, L.S.H., Gautvik, V.T., Shahdadfar, A., Gautvik, K.M. and Jemtland, R. (2008) Calmodulin-dependent kinase 1beta is expressed in the epiphyseal growth plate and regulates proliferation of mouse calvarial osteoblasts in vitro. Bone, 43, 700-707.
289. Confalonieri, F. and Duguet, M. (1995) A 200-amino acid ATPase module in search of a basic function. Bioessays, 17, 639-650.
290. Long, J.J., Leresche, A., Kriwacki, R.W. and Gottesfeld, J.M. (1998) Repression of TFIIH transcriptional activity and TFIIH-associated Cdk7 kinase activity at mitosis. Mol. Cell Biol., 18, 1467-1476.
291. Fröhlich, K.U., Fries, H.W., Rüdiger, M., Erdmann, R., Botstein, D. and Mecke, D. (1991) Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression. J. Cell Biol., 114, 443-453.
292. Yamanaka, K., Sasagawa, Y. and Ogura, T. (2011) Recent advances in p97/VCP/Cdc48 cellular functions. Biochim. Biophys. Acta., [Epub ahead of print]. doi:10.1016/j.bbamcr.2011.07.001.
293. Watts, G.D.J., Wymer, J., Kovach, M.J., Mehta, S.G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M.P. and Kimonis, V.E. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet., 36, 377-381.
294. Bersano, A., Del Bo, R., Lamperti, C., Ghezzi, S., Fagiolari, G., Fortunato, F., Ballabio, E., Moggio, M., Candelise, L., Galimberti, D. et al. (2009) Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol. Aging, 30, 752-758.
295. Johnson, J.O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V.M., Trojanowski, J.Q., Gibbs, J.R., Brunetti, M., Gronka, S., Wuu, J. et al. (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron, 68, 857-864.
296. David, D.C., Ittner, L.M., Gehrig, P., Nergenau, D., Shepherd, C., Halliday, G. and Gö tz, J. (2006) b-Amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics, 6, 6566-6577.
297. Kimura, Y. and Kakizuka, A. (2003) Polyglutamine diseases and molecular chaperones. IUBMB Life, 55, 337-345.
298. Higashiyama, H., Hirose, F., Yamaguchi, M., Inoue, Y.H., Fujikake, N., Matsukage, A. and Kakizuka, A. (2002) Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Cell Death Differ., 9, 264-273.
299. Griciuc, A., Aron, L., Roux, M.J., Klein, R., Giangrande, A. and Ueffing, M. (2010) Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet., 6, e1001075.
300. Granata, A., Schiavo, G. and Warner, T.T. (2009) TorsinA and dystonia: from nuclear envelope to synapse. J. Neurochem., 109, 1596-1609.
301. Sharma, N., Hewett, J., Ozelius, L.J., Ramesh, V., McLean, P.J., Breakefield, X.O. and Hyman, B.T. (2001) A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. Am. J. Pathol., 159, 339-344.
302. Cao, S., Gelwix, C.C., Caldwell, K.A. and Caldwell, G.A. (2005) Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci., 25, 3801-3812.
303. Caldwell, G.A., Cao, S., Sexton, E.G., Gelwix, C.C., Bevel, J.P. and Caldwell, K.A. (2003) Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum. Mol. Genet., 12, 307-319.
304. Krylova, S.M., Musheev, M., Nutiu, R., Li, Y., Lee, G. and Krylov, S.N. (2005) Tau protein binds single-stranded DNA sequence specifically-the proof obtained in vitro with non-equilibrium capillary electrophoresis of equilibrium mixtures. FEBS Lett., 579, 1371-1375.
305. Wei, Y., Qu, M.-H., Wang, X.-S., Chen, L., Wang, D.-L., Liu, Y., Hua, Q. and He, R.-Q. (2008) Binding to the minor groove of the double-strand, tau protein prevents DNA from damage by peroxidation. PloS ONE, 3, e2600.
306. Padmaraju, V., Indi, S.S. and Rao, K.S.J. (2010) New evidences on Tau-DNA interactions and relevance to neurodegeneration. Neurochem. Int., 57, 51-57.
307. Heck, M.M., Pereira, A., Pesavento, P., Yannoni, Y., Spradling, A.C. and Goldstein, L.S. (1993) The kinesin-like protein KLP61F is essential for mitosis in Drosophila. J. Cell Biol., 123, 665-679.
308. Goshima, G., Wollman, R., Goodwin, S.S., Zhang, N., Scholey, J.M., Vale, R.D. and Stuurman, N. (2007) Genes required for mitotic spindle assembly in Drosophila S2 cells. Science, 316, 417-421.
309. van den Wildenberg, S.M.J.L., Tao, L., Kapitein, L.C., Schmidt, C.F., Scholey, J.M. and Peterman, E.J.G. (2008) The homotetrameric kinesin-5 KLP61F preferentially crosslinks microtubules into antiparallel orientations. Curr. Biol., 18, 1860-1864.
310. Prasanth, K.V., Rajendra, T.K., Lal, A.K. and Lakhotia, S.C. (2000) Omega speckles-a novel class of nuclear speckles containing hnRNPs associated with noncoding hsr-omega RNA in Drosophila. J. Cell Sci., 113, 3485-3497.
311. Charroux, B., Angelats, C., Fasano, L., Kerridge, S. and Vola, C. (1999) The levels of the bancal product, a Drosophila homologue of vertebrate hnRNP K protein, affect cell proliferation and apoptosis in imaginal disc cells. Mol. Cell Biol., 19, 7846-7856.
312. Piao, Y.-S., Hayashi, S., Wakabayashi, K., Kakita, A., Aida, I., Yamada, M. and Takahashi, H. (2002) Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol., 103, 469-474.
313. Iseki, E., Matsumura, T., Marui, W., Hino, H., Odawara, T., Sugiyama, N., Suzuki, K., Sawada, H., Arai, T. and Kosaka, K. (2001) Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells. Acta Neuropathol., 102, 285-292.
314. Nelson, P.T. and Saper, C.B. (1995) Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol. Aging, 16, 315-323.
315. Sjöberg, M.K., Shestakova, E., Mansuroglu, Z., Maccioni, R.B. and Bonnefoy, E. (2006) Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization. J. Cell Sci., 119, 2025-2034.
316. Thurston, V.C., Pena, P., Pestell, R. and Binder, L.I. (1997) Nucleolar localization of the microtubule-associated protein tau in neuroblastomas using sense and anti-sense transfection strategies. Cell Motil. Cytoskel., 38, 100-110.
317. Qu, M.-H., Li, H., Tian, R., Nie, C.-L., Liu, Y., Han, B.-S. and He, R.-Q. (2004) Neuronal tau induces DNA conformational changes observed by atomic force microscopy. Neuroreport, 15, 2723-2727.
318. Kampers, T., Friedhoff, P., Biernat, J., Mandelkow, E.M. and Mandelkow, E. (1996) RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett., 399, 344-349.
319. Friedhoff, P., Schneider, A., Mandelkow, E.M. and Mandelkow, E. (1998) Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry, 37, 10223-10230.
320. Ginsberg, S.D., Crino, P.B., Lee, V.M., Eberwine, J.H. and Trojanowski, J.Q. (1997) Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann. Neurol., 41, 200-209.
321. Ginsberg, S.D., Galvin, J.E., Chiu, T.S., Lee, V.M., Masliah, E. and Trojanowski, J.Q. (1998) RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathol., 96, 487-494.
322. Broccolini, A., Engel, W.K., Alvarez, R.B. and Askanas, V. (2000) Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein. Am. J. Pathol., 156, 1151-1155.
323. Yu, J., Garfinkel, A.B. and Wolfner, M.F. (2002) Interaction of the essential Drosophila nuclear protein YA with P0/AP3 in the cytoplasm and in vitro: implications for developmental regulation of YA's subcellular location. Dev. Biol., 244, 429-441.
324. Yacoub, A., Kelley, M.R. and Deutsch, W.A. (1996) Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity. Nucl. Acids Res., 24, 4298-4303.
325. Frolov, M.V. and Birchler, J.A. (1998) Mutation in P0, a dual function ribosomal protein/apurinic/apyrimidinic endonuclease, modifies gene expression and position effect variegation in Drosophila. Genetics, 150, 1487-1495.
326. Bomsztyk, K., Denisenko, O. and Ostrowski, J. (2004) hnRNP K: one protein multiple processes. Bioessays, 26, 629-638.
327. Samuel, S.K., Spencer, V.A., Bajno, L., Sun, J.M., Holth, L.T., Oesterreich, S. and Davie, J.R. (1998) In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells. Cancer Res., 58, 3004-3008.
328. Blanchette, A.R., Fuentes Medel, Y.F. and Gardner, P.D. (2006) Cell-type-specific and developmental regulation of heterogeneous nuclear ribonucleoprotein K mRNA in the rat nervous system. Gene Expr. Patterns, 6, 596-606.
329. Thyagarajan, A. and Szaro, B.G. (2008) Dynamic endogenous association of neurofilament mRNAs with K-homology domain ribonucleoproteins in developing cerebral cortex. Brain Res., 1189, 33-42.
330. Mandal, M., Vadlamudi, R., Nguyen, D., Wang, R.A., Costa, L., Bagheri-Yarmand, R., Mendelsohn, J. and Kumar, R. (2001) Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J. Biol. Chem., 276, 9699-9704.
331. Habelhah, H., Shah, K., Huang, L., Ostareck-Lederer, A., Burlingame, A.L., Shokat, K.M., Hentze, M.W. and Ronai, Z. (2001) ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol., 3, 325-330.
332. Kai, N., Mishina, M. and Yagi, T. (1997) Molecular cloning of Fyn-associated molecules in the mouse central nervous system. J. Neurosci. Res., 48, 407-424.
333. Shirazi, S.K. and Wood, J.G. (1993) The protein tyrosine kinase, fyn, in Alzheimer's disease pathology. Neuroreport, 4, 435-437.
334. Lee, G., Thangavel, R., Sharma, V.M., Litersky, J.M., Bhaskar, K., Fang, S.M., Do, L.H., Andreadis, A., Van Hoesen, G. and Ksiezak-Reding, H. (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci., 24, 2304-2312.
335. Ho, G.J., Hashimoto, M., Adame, A., Izu, M., Alford, M.F., Thal, L.J., Hansen, L.A. and Masliah, E. (2005) Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiol. Aging, 26, 625-635.
336. Chin, J., Palop, J.J., Puoliväli, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E. and Mucke, L. (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci., 25, 9694-9703.
337. Bhaskar, K., Yen, S.-H. and Lee, G. (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J. Biol. Chem., 280, 35119-35125.
338. Ostrowski, J., Kawata, Y., Schullery, D.S., Denisenko, O.N., Higaki, Y., Abrass, C.K. and Bomsztyk, K. (2001) Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA. Proc. Natl Acad. Sci. USA, 98, 9044-9049.
339. Mikula, M. and Bomsztyk, K. (2011) Direct recruitment of ERK cascade components to inducible genes is regulated by the heterogeneous nuclear ribonucleoprotein K (HNRNP K). J. Biol. Chem., 286, 9763-9775.
340. Estes, P.S., O'Shea, M., Clasen, S. and Zarnescu, D.C. (2008) Fragile X protein controls the efficacy of mRNA transport in Drosophila neurons. Mol. Cell Neurosci., 39, 170-179.
341. Bassell, G.J. and Warren, S.T. (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron, 60, 201-214.
342. Garber, K.B., Visootsak, J. and Warren, S.T. (2008) Fragile X syndrome. Eur. J. Hum. Genet., 16, 666-672.
343. Oostra, B.A. and Willemsen, R. (2009) FMR1: a gene with three faces. Biochim. Biophys. Acta, 1790, 467-477.
344. Kwong, L.K., Neumann, M., Sampathu, D.M., Lee, V.M.-Y. and Trojanowski, J.Q. (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol., 114, 63-70.
345. Liscic, R.M., Grinberg, L.T., Zidar, J., Gitcho, M.A. and Cairns, N.J. (2008) ALS and FTLD: two faces of TDP-43 proteinopathy. Eur. J. Neurol., 15, 772-780.
346. Wilson, A.C., Dugger, B.N., Dickson, D.W. and Wang, D.-S. (2011) TDP-43 in aging and Alzheimer's disease-a review. Int. J. Clin. Exp. Pathol., 4, 147-155.
347. Buchan, J.R. and Parker, R. (2009) Eukaryotic stress granules: the ins and outs of translation. Mol. Cell, 36, 932-941.
348. Kim, S.H., Dong, W.K., Weiler, I.J. and Greenough, W.T. (2006) Fragile X mental retardation protein shifts between polyribosomes and stress granules after neuronal injury by arsenite stress or in vivo hippocampal electrode insertion. J. Neurosci., 26, 2413-2418.
349. Linder, B., Plöttner, O., Kroiss, M., Hartmann, E., Laggerbauer, B., Meister, G., Keidel, E. and Fischer, U. (2008) Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP. Hum. Mol. Genet., 17, 3236-3246.
350. McDonald, K.K., Aulas, A., Destroismaisons, L., Pickles, S., Beleac, E., Camu, W., Rouleau, G.A. and Vande Velde, C. (2011) TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet., 20, 1400-1410.
351. Fukuda, T., Naiki, T., Saito, M. and Irie, K. (2009) hnRNP K interacts with RNA binding motif protein 42 and functions in the maintenance of cellular ATP level during stress conditions. Genes Cells, 14, 113-128.
352. De Diego Otero, Y., Severijnen, L.-A., van Cappellen, G., Schrier, M., Oostra, B. and Willemsen, R. (2002) Transport of fragile X mental retardation protein via granules in neurites of PC12 cells. Mol. Cell Biol., 22, 8332-8341.
353. Antar, L.N., Dictenberg, J.B., Plociniak, M., Afroz, R. and Bassell, G.J. (2005) Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav., 4, 350-359.
354. Zhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E.B., Xie, S.X., Joyce, S., Li, C. et al. (2005) Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl Acad. Sci. USA, 102, 227-231.
355. Brunden, K.R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J.S., Hogan, A.-M.L., Iba, M., James, M.J., Xie, S.X., Ballatore, C. et al. (2010) Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci., 30, 13861-13866.
356. Takahashi, Y., Hirose, F., Matsukage, A. and Yamaguchi, M. (1999) Identification of three conserved regions in the DREF transcription factors from Drosophila melanogaster and Drosophila virilis. Nucl. Acids Res., 27, 510-516.
357. Freeman, M. (1996) Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell, 87, 651-660.
358. Lu, Y., Ferris, J. and Gao, F.-B. (2009) Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. Mol. Brain, 2, 30.
359. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498-2504.
360. Thomas, P.D., Campbell, M.J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A. and Narechania, A. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res., 13, 2129-2141.